ASH Meeting on Hematologic Malignancies

    CLL: No symptoms, no treatment still appropriate

    EXPERT ANALYSIS FROM MHM 2015 CHICAGO (FRONTLINE MEDICAL NEWS) – Despite exciting new advances ...

    author_avatar
    Frontline Medical News

    Data support subcutaneous bortezomib in multiple myeloma

    AT MHM 2015 CHICAGO (FRONTLINE MEDICAL NEWS) – Subcutaneous and intravenous bortezomib performed comparably ...

    author_avatar
    Frontline Medical News

    HELIOS trial: Ibrutinib safely boosts survival in CLL/SLL

    AT MHM 2015 CHICAGO (FRONTLINE MEDICAL NEWS) – Adding ibrutinib to bendamustine and rituximab ...

    author_avatar
    Frontline Medical News

    Statins curb skeletal events in multiple myeloma

    AT MHM 2015 CHICAGO (FRONTLINE MEDICAL NEWS) – Statin use is associated with a ...

    author_avatar
    Frontline Medical News
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call